Navigation Links
Healthier Healing for Hip Resurfacing - ICAP Ocean Tomo Announces Auction of an Advanced Hip Cap for Electromagnetic Tissue Stimulation by Neue Magnetodyn.
Date:3/15/2011

CHICAGO, March 15, 2011 /PRNewswire/ -- Developed by Neue Magnetodyn and represented by ICAP Ocean Tomo, this technology discloses an advanced hip cap for electromagnetic tissue stimulation. The assets in this portfolio will be auctioned off at ICAP Ocean Tomo's Spring 2011 Live IP Auction on March 31, 2011 in New York City.

(Logo: https://photos.prnewswire.com/prnh/20100614/CG20517LOGO)

Key Characteristics & Benefits

This patent discloses the following:

  • An advanced hip implant that facilitates fast tissue growth using electrical stimulation. This mitigates the risk of degeneration and necrosis.
  • The free end of the shaft of a standard hip cap encapsulates a pick-up coil, electrically coupled with the inner wall of the shaft, collectively forming an electrode.
  • A low frequency alternating current is induced in the pick-up coil to stimulate tissue growth and maintain the vitality of the bone covered by the cap.
  • By promoting angiogenesis and intensive revascularization of the femur neck, electromagnetic osteosti repeated stimulation "on demand" is possible over the lifetime of the implantmulation which restores the vitality of existing bone stock, and prolongs the life of the implant.
  • Repeated stimulation "on demand" is possible over the lifetime of the implant.
  • In the case of hip resurfacing, the active device stimulates the bone under the cap and extends the effective life of the prosthesis before replacement needs to be considered.
  • This device actively addresses a potential problem with hip resurfacing – the inherent risk of necrosis of the head of the femur.
  • Several CE certified products using this Magnetodyn technology are in clinical use.

Market Potential

This lot should be of interest to prosthetic device manufacturers, healthcare service providers, and entities manufacturing biomaterials and orthopedic surgery devices. The buyer will acquire a world-wide monopolistic position in the application of the technology in the field of hip resurfacing

  • Growing at an 8% CAGR, the global hip and knee implants market is forecasted to reach $21.7 billion by 2016, of this, the hip implant market is expected to be worth $8.7 billion.(1)

To learn more about the assets available for sale in this portfolio:

Contact Dean Becker of ICAP Ocean Tomo at Dean.Becker@us.icap.com

About ICAP Ocean Tomo LLC

ICAP Ocean Tomo is the intellectual property brokerage division of ICAP and the world's premier patent auction firm.

About ICAP

ICAP is the world's premier interdealer broker and provider of post trade services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, foreign exchange, emerging markets, equities and equity derivatives through voice and electronic networks. ICAP plc was added to the FTSE 100 Index on 30 June 2006. For more information go to www.icap.com.

(1) http://www.marketwire.com/press-release/Hip-Knee-Implants-Market-to-Reach-21-Billion-by-2016-1308186.htm


'/>"/>
SOURCE ICAP Ocean Tomo
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Many Americans Enjoying Longer, Healthier Lives Due to Medical Innovation and New Therapies
2. Americans Living Longer, Healthier Lives Due to Medical Innovation and New Therapies
3. Americas Pharmaceutical Research and Biotechnology Companies Lead the Charge Toward Longer, Healthier Lives for Americans
4. GREENGUARDs First Exhibit at HEALTHCARE DESIGN.10 to Help Architects and Designers Specify Healthier Products More Easily and Efficiently
5. Studies Show Body Mass Index Has No Effect on Resolution and Healing of GERD Symptoms
6. Derma Sciences to Enter Phase II Development of Wound Healing Product That May Use Bodys Own Naturally Occurring Stem Cells
7. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
8. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
9. Ceremeds OSTENE(R) Improves Bone Fusion and Healing After Surgery, New Study Shows
10. TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis
11. Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... "The World Market for Companion Diagnostic Tests" report to ... World Market for Companion Diagnostics The World ... diagnostic and personalized medicine diagnostics. Market analysis in the report ... Diagnostics Test Market (In Vitro Diagnostic Kits) by Region (N. ...
(Date:6/24/2016)... , Belgium , June 24, ... VNRX), today announced the appointment of Dr. ... Directors as a Non-Executive Director, effective June 23, ... Audit, Compensation and Nominations and Governance Committees.  As ... Futcher will provide independent expertise and strategic counsel ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):